Hepatitis C Perspective

 
 

  • Episode 12: Think About Heart Transplant Evaluation Like This   Drs Michelle Kittleson and James Fang cap off the podcast series by discussing difficult cardiac transplantation decision points, including LVADs and the latest innovations in cardiac transplantation.
  • AASLD 2023 Read clinically focused news coverage of key developments from AASLD 2023.
  • ACG 2023 Read clinically focused news coverage of key developments from ACG 2023
  • 10 Questions Answered About New Liver Disease Term 'MASLD' Dr William Balistreri on the reasons why an international panel is phasing out NAFLD/NASH.
  • ILC 2023 Read clinically focused news coverage of key developments from ILC 2023
  • DDW 2023 Read clinically focused news coverage of key developments from DDW 2023.
  • S2 Episode 2: COVID-19 and HIV   Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions.
  • S2 Episode 1: Anticipating and Managing HIV Drug Interactions   Drs Michael S. Saag and Charles W. Flexner discuss the mechanisms of drug-drug interactions and the promise and limitations of longer-acting HIV therapeutics for both treatment and prevention.
  • Don't Fear Testing for, and De-labeling, Penicillin Allergy Use this simple proactive approach to remove the burden of penicillin allergy from patients who are mislabeled.
  • The 5 Biggest Changes in the 2023 Adult Vaccine Schedules   AMA Liaison to ACIP Dr Sandra Fryhofer gives a quick tour of the 2023 vaccination schedules, highlighting what's new for this year.
  • A New (Old) Drug Joins the COVID Fray, and Guess What? It Works   Approving this drug would double our COVID treatment options, says Dr Perry Wilson in this week's Impact Factor.
  • Much-Needed Guidance Arrives on Drug-Induced Liver Injury Dr Nancy Reau speaks with Dr Robert Fontana, the co-author of recent guidance from the AASLD on how to diagnose and manage the harmful consequences of certain drugs and unregulated supplements.
  • My Approach to the Annual Wellness Visit Many adults skip the yearly "physical." But these regular visits are the foundation of the patient-physician partnership.
  • AASLD 2022 Read clinically focused news coverage of key developments from AASLD 2022
  • California Should Invest in Harm Reduction to Combat Monkeypox One clear way to reduce monkeypox transmission is through harm reduction programs aimed at substance users, but funding is at risk.
  • ACG 2022 Read clinically focused news coverage of key developments from ACG 2022
  • Paxlovid Rebound in COVID-19: Where We Stand on Drug Regimens   Drs Robert Glatter and Paul Auwaerter discuss Paxlovid rebound and recommendations for patients with COVID-19.
  • Don't Overlook NAFLD in Lean Patients Dr Nancy Reau speaks with gastroenterologist Dr Michelle Long about the challenges of identifying and treating NAFLD in patients without obesity.
  • Treating Monkeypox: Q&A with the CDC's John T. Brooks, MD Sexually active men who have sex with men are most at risk for infection with the virus, which can cause excruciatingly painful lesions and even scarring.
  • S2 Episode 2: How to Optimize Shared Decision-Making in Psoriatic Arthritis   Drs Stanley Cohen and Eric Ruderman dig into three challenging case studies to discuss shared decision-making strategies in the treatment and management of psoriatic arthritis.